Merck & Co., Inc. (MRK)
NYSE · Healthcare
Merck & Co., Inc. Long Term Debt 2007–2025
Merck & Co., Inc. annual long term debt history from 2008 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Merck & Co., Inc. long term debt as of December 31, 2025: 46.75B, a 35.66% increase year-over-year.
- Merck & Co., Inc. long term debt for 2025 were 46.75B, a 35.66% increase from 2024.
- Merck & Co., Inc. long term debt for 2024 were 34.46B, a 2.31% increase from 2023.
- Merck & Co., Inc. long term debt for 2023 were 33.68B, a 17.18% increase from 2022.
- Merck & Co., Inc. long term debt for 2022 were 28.75B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Merck & Co., Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $46,750 |
| 2024 | $34,462 |
| 2023 | $33,683 |
| 2022 | $28,745 |
| 2021 | $30,690 |
| 2020 | $25,360 |
| 2019 | $22,736 |
| 2018 | $19,806 |
| 2017 | $21,353 |
| 2016 | $24,274 |
| 2010 | $15,482 |
| 2009 | $17,500 |
| 2008 | $3,943 |
Merck & Co. Inc. Long Term Debt — FAQ
Merck & Co. Inc. (MRK) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MRK's long term debt history?
The chart and table above show Merck & Co. Inc.'s long term debt by year and by quarter, including the growth rate.